<DOC>
	<DOCNO>NCT02603406</DOCNO>
	<brief_summary>Neovascularization Induced Mechanical Barrier disrUption Systemic erythropoietin patient cerebral perfusion deficit ( NIMBUS trial )</brief_summary>
	<brief_title>Neovascularization Induced Mechanical Barrier disrUption Systemic Erythropoietin Patients With Cerebral Perfusion Deficits</brief_title>
	<detailed_description />
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Acute period ( ischemic stroke confirmation DWI TIA within 7 day symptom onset ) Below 20 point initial NIHSS score within 7 day stroke onset enrolment . Confirmation atherosclerotic stenoocclusive stroke mechanism ( proximal cerebral artery ) CTA MRA . At least hemodynamically , perfusion status candidate stage II III ( decrease regional Cerebral blood flow CBF map ) If female childbearing potential Informed consent Primary intracerebral haemorrhage ( ICH ) , parenchymal haemorrhagic transformation infarction ( type PHI PHII define ECASS ) , subarachnoid haemorrhage ( SAH ) , arteriovenous malformation ( AVM ) , cerebral aneurysm , cerebral neoplasm Treated thrombolytic &lt; 24 hour ( &gt; 24 hour exclude ICH eligible ) Score &gt; =1 NIHSS item 1a Prestroke mRS score &gt; =2 Uncontrolled hypertension Previous treatment erythropoietin At screening : Hemoglobin &gt; 15 mg/dl , prolong PT PTT , serum Cr &gt; 2.0 mg/dl , thrombocytopenia neutropenia define low limit normal platelet count white blood cell count , respectively ( absolute neutrophil count &gt; 1800/mm3 required participation ) , &gt; 2 time normal liver function test ( SGOT , SGPT , total bilirubin )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>